000 01230 a2200313 4500
005 20250512031022.0
264 0 _c19851202
008 198512s 0 0 eng d
022 _a0042-6822
024 7 _a10.1016/0042-6822(85)90239-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlofsson, S
245 0 0 _aThe antiherpes drug (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU) interferes with formation of N-linked and of O-linked oligosaccharides of the herpes simplex virus type 1 glycoprotein C.
_h[electronic resource]
260 _bVirology
_cNov 1985
300 _a201-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xpharmacology
650 0 4 _aBromodeoxyuridine
_xanalogs & derivatives
650 0 4 _aCell Line
650 0 4 _aOligosaccharides
_xbiosynthesis
650 0 4 _aSimplexvirus
_xdrug effects
650 0 4 _aTunicamycin
_xpharmacology
650 0 4 _aViral Envelope Proteins
650 0 4 _aViral Proteins
_xbiosynthesis
700 1 _aLundström, M
700 1 _aDatema, R
773 0 _tVirology
_gvol. 147
_gno. 1
_gp. 201-5
856 4 0 _uhttps://doi.org/10.1016/0042-6822(85)90239-9
_zAvailable from publisher's website
999 _c3003878
_d3003878